Chronic Lower Back Pain epidemiology report gives a thorough understanding of the Chronic Lower Back Pain by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. 

Chronic Lower Back Pain Epidemiology Forecast | Chronic Lower Back Pain Prevalent population

<h2 class="MsoNormal">Key Highlights</h2>
<ul>
<li class="MsoNormal">DelveInsight&rsquo;s analyst projects that the total diagnosed prevalent of Chronic Lower Back Pain cases in 7MM were approximately 67 million in 2022 and these cases are going to increase because of changes in psychosocial and physical work demands, risk factors for LBP (2023&ndash;2034).</li>
<li class="MsoNormal">According to DelveInsight&rsquo;s analysis, the total number of diagnosed prevalent cases of CLBP in the US was found to be nearly 30 million in 2022 and is estimated to increase with a significant CAGR throughout the forecast period.</li>
<li class="MsoNormal">In 2022, the total number of diagnosed prevalent cases of CLBP was approximately 27 million in EU4 and the UK, which is anticipated to increase during the study period [2020&ndash;2034].</li>
<li class="MsoNormal">According to DelveInsight&rsquo;s estimates, Japan accounted for nearly 16% of the total number of diagnosed prevalent cases of CLBP in the 7MM in 2022.</li>
</ul>
&nbsp;
DelveInsight&rsquo;s &ldquo;Chronic Lower Back Pain (CLBP) &ndash; Epidemiology &ndash; 2034&rdquo; report delivers an in-depth understanding of Chronic Lower Back Pain, historical and forecasted epidemiology of Chronic Lower Back Pain in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
<h2 class="MsoNormal">Geography Covered</h2>
<ul>
<li class="MsoNormal">The United States</li>
<li class="MsoNormal">EU4 (Germany, France, Italy, and Spain) and the United Kingdom</li>
<li class="MsoNormal">Japan</li>
</ul>
Study Period: 2020&ndash;2034
<h2 class="MsoNormal">Chronic Lower Back Pain Disease Understanding</h2>
Chronic Lower Back Pain Overview
Chronic Lower Back Pain (CLBP) is sudden damage to the brain caused by a blow or jolt to the head. Common causes include car or motorcycle crashes, falls, sports injuries, and assaults. It is evident that many people dealing with persistent chronic pain also have feelings of anxiety or depression, which worsen their CLBP. A valuable approach involves screening for these psychological conditions and providing patients with antidepressants or counseling when there is a psychological component to their pain syndrome.
&nbsp;
Chronic Lower Back Pain Diagnosis
Despite ongoing advancements in medical diagnostic techniques, the majority of back pain cases still lack a definitive diagnosis of the underlying source. Many patients undergo inappropriate treatments without a clear understanding of the origin of their back pain, leading to significant financial expenditures on diagnostic evaluations that often fail to identify the precise cause. This persistent challenge highlights an unmet need for more effective and accurate diagnostic tools to discern the physical and non-physical sources of back pain, ultimately improving the targeted and efficient management of this common health issue.
Further details related to diagnosis are provided in the report&hellip;
<h2 class="MsoNormal">Chronic Lower Back Pain Epidemiology</h2>
As the market is derived using the patient-based model, the Chronic Lower Back Pain epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by Prevalent Cases of CLBP, Diagnosed Prevalent Cases of CLBP, Gender-specific Diagnosed Prevalent Cases of CLBP, and Age-specific Diagnosed Prevalent Cases of CLBP in the 7MM covering the United States, EU4 countries (Germany, France, Italy, and Spain) and the United Kingdom, and Japan, from 2020 to 2034.
<ul>
<li class="MsoNormal">According to DelveInsight estimations, approximately 80 million prevalent cases of CLBP were found in 2022 in the 7MM.</li>
<li class="MsoNormal">The United States exhibited the highest diagnosed prevalent population of CLBP, as compared to other 7MM countries. As per DelveInsight&rsquo;s estimations, the total number of diagnosed prevalent cases with Chronic Lower Back Pain in the US was around 30 million in 2022 and is projected to increase during the forecast period owing to the increasing prevalent population.</li>
<li class="MsoNormal">According to DelveInsight&rsquo;s estimates, the Diagnosed Prevalent Cases of CLBP in EU4 and the UK were found to be 27 million in 2022. Throughout the study period, it is anticipated that there will be a substantial increase in cases for all contributing countries, except for Germany, where the cases are projected to decline due to factors such as a decreasing population and other factors. The highest proportion of CLBP cases was reported in Spain among the EU4 countries, while the least number of cases was found in France.</li>
<li class="MsoNormal">The estimates show the Diagnosed Prevalent Cases of CLBP in Japan was found to be around 10 million in 2022, which is estimated to decrease by 2034 because of the decreasing country population.</li>
<li class="MsoNormal">The Gender-specific Diagnosed Prevalent Cases of CLBP in the 7MM were approximately 37 million for females and 30 million for males in 2022 and are expected to increase within the forecast period (2023&ndash;2034). The increased prevalence in females is likely due to a combination of factors, including psychological factors, female hormone fluctuations, and others.</li>
<li class="MsoNormal">As per DelveInsight&rsquo;s analysis, the Age-specific Diagnosed Prevalent Cases of CLBP based on age were categorized into 18-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, and&nbsp; 70+ years. The higher number of cases (~7 million) was accounted for by the 70+ years age group in 2022 in the US.</li>
</ul>
<h2 class="MsoNormal">KOL Views</h2>
To gaze into the epidemiology insights of the real world, we take KOLs and SMEs&rsquo; opinions working in the domain through primary research to fill the data gaps and validate our secondary research on disease prevalence.
&nbsp;
DelveInsight&rsquo;s analysts connected with 20+ KOLs to gather insights; however, interviews were conducted with 10+ KOLs in the 7MM. Centers such as the Princeton Spine &amp; Joint Center, Department of Anesthesiology, University of Michigan, University Hospital Giessen, Germany, University of Salerno, Italy and others were contacted. Their opinion helps understand and validate current disease prevalence, gender involved with the disease, diagnosis rate, and diagnostic criteria.
<h2 class="MsoNormal">Scope of the Report</h2>
<ul>
<li class="MsoNormal">The report covers a segment of key events, an executive summary, descriptive overview of Chronic Lower Back Pain, explaining its causes, signs and symptoms, and currently available diagnostic algorithms and guidelines.</li>
<li class="MsoNormal">Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of diagnosis rate, disease progression, and diagnosis guidelines.</li>
<li class="MsoNormal">The report provides an edge for understanding trends, expert insights/KOL views, and patient journeys in the 7MM.</li>
<li class="MsoNormal">A detailed review of current challenges in establishing the diagnosis.</li>
</ul>
<h2 class="MsoNormal">Chronic Lower Back Pain Report Insights</h2>
<ul>
<li class="MsoNormal">Patient Population</li>
<li class="MsoNormal">Country-wise Epidemiology Distribution</li>
<li class="MsoNormal">Prevalent Cases of CLBP</li>
<li class="MsoNormal">Diagnosed Prevalent Cases of CLBP</li>
<li class="MsoNormal">Gender-specific Diagnosed Prevalent Cases of CLBP</li>
<li class="MsoNormal">Age-specific Diagnosed Prevalent Cases of CLBP</li>
</ul>
<h2 class="MsoNormal">Chronic Lower Back Pain Report Key Strengths</h2>
<ul>
<li class="MsoNormal">12 years Forecast</li>
<li class="MsoNormal">The 7MM Coverage</li>
<li class="MsoNormal">Chronic Lower Back Pain Epidemiology Segmentation</li>
</ul>
<h2 class="MsoNormal">Chronic Lower Back Pain Report Assessment</h2>
<ul>
<li class="MsoNormal">Current Diagnostic Practices Patient Segmentation</li>
</ul>
<h2 class="MsoNormal">Epidemiology Insights</h2>
<ul>
<li class="MsoNormal">What are the disease risk, burdens, and unmet needs of Chronic Lower Back Pain? What will be the growth opportunities across the 7MM concerning the patient population of Chronic Lower Back Pain?</li>
<li class="MsoNormal">What is the historical and forecasted Chronic Lower Back Pain patient pool in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan?</li>
<li class="MsoNormal">Why is the prevalent cases of CLBP in Japan lower than the US?</li>
<li class="MsoNormal">Which country has a high patient share for CLBP?</li>
</ul>
<h2 class="MsoNormal">Reasons to Buy</h2>
<ul>
<li class="MsoNormal">Insights on patient burden/disease, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.</li>
<li class="MsoNormal">To understand the Chronic Lower Back Pain prevalence cases in varying geographies over the coming years.</li>
<li class="MsoNormal">A detailed overview of Gender and Age-specific diagnosed prevalence of CLBP.</li>
<li class="MsoNormal">To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis options.</li>
<li class="MsoNormal">Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.</li>
</ul>
<h2 class="MsoNormal">Frequently Asked Questions</h2>
1. What is the forecast period covered in the report?
The Chronic Lower Back Pain Epidemiology report for the 7MM covers the forecast period from 2023 to 2034, providing a projection of epidemiology dynamics and trends during this timeframe.
&nbsp;
2. Out of all EU4 countries and the UK, which country had the highest population of Chronic Lower Back Pain (CLBP) cases in 2022?
The highest cases of Chronic Lower Back Pain was found in the Germany among EU4 and the UK in 2022.
&nbsp;
3. How is epidemiological data collected and analyzed for forecasting purposes?
Epidemiological data is collected through surveys, clinical studies, health records, and other sources. It is then analyzed to calculate disease rates, identify trends, and project future disease burdens using mathematical models.
&nbsp;
4. Out of all 7MM countries, which country had the highest population of Chronic Lower Back Pain (CLBP) cases in 2022?
&nbsp;
The highest cases of Chronic Lower Back Pain were found in the US among the 7MM in 2022.

1. Key Insights
2. Report Introduction
3. Chronic Lower Back Pain (CLBP) Epidemiology Overview
3.1. Patient Share (%) Distribution of CLBP in 2020
3.2. Patient Share (%) Distribution of CLBP in 2034
4. Epidemiology Methodology of CLBP
5. Executive Summary of CLBP
6. Key Events
7. Disease Background and Overview
7.1. Introduction
7.2. Symptoms
7.3. Etiology
7.4. Pathophysiology
7.5. Neurodegenerative Conditions Associated With CLBP
7.6. Biomarkers
7.7. Diagnosis
7.7.1. AAPT Diagnostic Criteria for CLBP
7.7.2. Test for CLAB diagnosis
7.7.3. Imaging Guidelines
8. Epidemiology and Patient Population
8.1. Key Findings
8.2. Assumptions and Rationale: The 7MM
8.3. Total Prevalent Cases of CLBP in the 7MM
8.4. Total Diagnosed Prevalent Cases of CLBP in the 7MM
8.5. The United States
8.5.1. Total Prevalent Cases of CLBP in the United States
8.5.2. Total Diagnosed Prevalent Cases of CLBP in the United States
8.5.3. Gender-specific Diagnosed Prevalent Cases of CLBP in the United States
8.5.4. Age-specific Diagnosed Prevalent Cases of CLBP in the United States
8.6. EU4 and the UK
8.6.1. Germany
8.6.1.1. Total Prevalent Cases of CLBP in Germany
8.6.1.2. Total Diagnosed Prevalent Cases of CLBP in Germany
8.6.1.3. Gender-specific Diagnosed Prevalent Cases of CLBP in Germany
8.6.1.4. Age-specific Diagnosed Prevalent Cases of CLBP in Germany
8.6.2. France
8.6.2.1. Total Prevalent Cases of CLBP in France
8.6.2.2. Total Diagnosed Prevalent Cases of CLBP in France
8.6.2.3. Gender-specific Diagnosed Prevalent Cases of CLBP in France
8.6.2.4. Age-specific Diagnosed Prevalent Cases of CLBP in France
8.6.3. Italy
8.6.3.1. Total Prevalent Cases of CLBP in Italy
8.6.3.2. Total Diagnosed Prevalent Cases of CLBP in Italy
8.6.3.3. Gender-specific Diagnosed Prevalent Cases of CLBP in Italy
8.6.3.4. Age-specific Diagnosed Prevalent Cases of CLBP in Italy
8.6.4. Spain
8.6.4.1. Total Prevalent Cases of CLBP in Spain
8.6.4.2. Total Diagnosed Prevalent Cases of CLBP in Spain
8.6.4.3. Gender-specific Diagnosed Prevalent Cases of CLBP in Spain
8.6.4.4. Age-specific Diagnosed Prevalent Cases of CLBP in Spain
8.6.5. UK
8.6.5.1. Total Prevalent Cases of CLBP in the UK
8.6.5.2. Total Diagnosed Prevalent Cases of CLBP in the UK
8.6.5.3. Gender-specific Diagnosed Prevalent Cases of CLBP in the UK
8.6.5.4. Age-specific Diagnosed Prevalent Cases of CLBP in the UK
8.7. Japan
8.7.1. Total Prevalent Cases of CLBP in Japan
8.7.2. Total Diagnosed Prevalent Cases of CLBP in Japan
8.7.3. Gender-specific Diagnosed Prevalent Cases of CLBP in Japan
8.7.4. Age-specific Diagnosed Prevalent Cases of CLBP in Japan
9. Patient Journey
10. Key Opinion Leaders&rsquo; Views
11. Appendix
11.1. Bibliography
11.2. Acronyms and Abbreviations
11.3. Report Methodology
12. DelveInsight Capabilities
13. Disclaimer
 
14. About DelveInsight

DelveInsight's "Chronic Lower Back Pain (CLBP) - Epidemiology Forecast to 2034" report delivers an in-depth understanding of the disease, historical and forecasted Chronic Lower Back Pain (CLBP) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Chronic Lower Back Pain (CLBP) - Epidemiology Forecast - 2034

DelveInsight's Chronic Lower Back Pain - Epidemiology Forecast 2032 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of CLBP in the...